162 research outputs found

    Spatial Memory Performance in Chronic Heart Failure.

    Full text link
    Twenty five to fifty percent of heart failure (HF) patients have cognitive dysfunction, including spatial memory dysfunction (e. g. inability to find their way or remember where belongings belong), from cerebral hypoperfusion and hippocampal injury. Spatial memory dysfunction decreases one’s ability to function independently (e.g. navigate to familiar places). Egocentric (relationship between self and object) spatial memory was worse in HF patients compared with healthy adults. However, literature about allocentric (relationship between objects in the environment) spatial memory in HF patients is limited. Specific aims were to: 1) compare allocentric spatial memory of HF patients and healthy adults; 2) determine relationships between allocentric and egocentric measures of spatial memory; and 3) examine the influence of gender, group, perceived cognitive activity, and perceived functional capacity on spatial memory. HF patients (32) and healthy adults (32) were recruited for a comparative design study. During two consecutive days, participants completed a virtual reality measure of spatial memory and learning, and, tests of memory, attention, and executive function. Perceived cognitive activity and functional capacity were measured. Worse, albeit non-significant spatial memory and learning scores were found in HF patients compared with healthy adults. Significant differences were found in spatial memory, using a mean score. Correlations between allocentric (path length, time to target) and egocentric measures (figure copy and figure memory recall, Corsi Block-tapping forward and backward) were non-significant. Gender, group, perceived cognitive activity, perceived functional capacity and age explained 13% of time spent in target quadrant (p = .020) and 4% of heading error (p = .184) during spatial memory testing. Age was the only significant independent predictor. HF patients had worse spatial memory and learning mean scores compared with healthy adults. Allocentric and egocentric measures of spatial memory have distinct properties and this should be considered in study design. Older age was a predictor of spatial memory performance in HF patients and healthy adults. Age is a known predictor but it may be related to an egocentric rather than an allocentric frame of reference. Future studies need to focus on other predictors of allocentric spatial memory.PHDNursingUniversity of Michigan, Horace H. Rackham School of Graduate Studieshttp://deepblue.lib.umich.edu/bitstream/2027.42/110450/1/priley_1.pd

    Risk of bias assessments in individual participant data meta-analyses of test accuracy and prediction models:a review shows improvements are needed

    Get PDF
    OBJECTIVES: Risk of bias assessments are important in meta-analyses of both aggregate and individual participant data (IPD). There is limited evidence on whether and how risk of bias of included studies or datasets in IPD meta-analyses (IPDMAs) is assessed. We review how risk of bias is currently assessed, reported, and incorporated in IPDMAs of test accuracy and clinical prediction model studies and provide recommendations for improvement.STUDY DESIGN AND SETTING: We searched PubMed (January 2018-May 2020) to identify IPDMAs of test accuracy and prediction models, then elicited whether each IPDMA assessed risk of bias of included studies and, if so, how assessments were reported and subsequently incorporated into the IPDMAs.RESULTS: Forty-nine IPDMAs were included. Nineteen of 27 (70%) test accuracy IPDMAs assessed risk of bias, compared to 5 of 22 (23%) prediction model IPDMAs. Seventeen of 19 (89%) test accuracy IPDMAs used Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2), but no tool was used consistently among prediction model IPDMAs. Of IPDMAs assessing risk of bias, 7 (37%) test accuracy IPDMAs and 1 (20%) prediction model IPDMA provided details on the information sources (e.g., the original manuscript, IPD, primary investigators) used to inform judgments, and 4 (21%) test accuracy IPDMAs and 1 (20%) prediction model IPDMA provided information or whether assessments were done before or after obtaining the IPD of the included studies or datasets. Of all included IPDMAs, only seven test accuracy IPDMAs (26%) and one prediction model IPDMA (5%) incorporated risk of bias assessments into their meta-analyses. For future IPDMA projects, we provide guidance on how to adapt tools such as Prediction model Risk Of Bias ASsessment Tool (for prediction models) and QUADAS-2 (for test accuracy) to assess risk of bias of included primary studies and their IPD.CONCLUSION: Risk of bias assessments and their reporting need to be improved in IPDMAs of test accuracy and, especially, prediction model studies. Using recommended tools, both before and after IPD are obtained, will address this.</p

    Enhanced Immunogenicity, Mortality Protection, and Reduced Viral Brain Invasion by Alum Adjuvant with an H5N1 Split-Virion Vaccine in the Ferret

    Get PDF
    Pre-pandemic development of an inactivated, split-virion avian influenza vaccine is challenged by the lack of pre-existing immunity and the reduced immunogenicity of some H5 hemagglutinins compared to that of seasonal influenza vaccines. Identification of an acceptable effective adjuvant is needed to improve immunogenicity of a split-virion avian influenza vaccine.No serum antibodies were detected after vaccination with unadjuvanted vaccine, whereas alum-adjuvanted vaccination induced a robust antibody response. Survival after unadjuvanted dose regimens of 30 µg, 7.5 µg and 1.9 µg (21-day intervals) was 64%, 43%, and 43%, respectively, yet survivors experienced weight loss, fever and thrombocytopenia. Survival after unadjuvanted dose regimen of 22.5 µg (28-day intervals) was 0%, suggesting important differences in intervals in this model. In contrast to unadjuvanted survivors, either dose of alum-adjuvanted vaccine resulted in 93% survival with minimal morbidity and without fever or weight loss. The rarity of brain inflammation in alum-adjuvanted survivors, compared to high levels in unadjuvanted vaccine survivors, suggested that improved protection associated with the alum adjuvant was due to markedly reduced early viral invasion of the ferret brain.Alum adjuvant significantly improves efficacy of an H5N1 split-virion vaccine in the ferret model as measured by immunogenicity, mortality, morbidity, and brain invasion

    Abstracts from the NIHR INVOLVE Conference 2017

    Get PDF
    n/

    Erratum to: Methods for evaluating medical tests and biomarkers

    Get PDF
    [This corrects the article DOI: 10.1186/s41512-016-0001-y.]

    Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.

    Get PDF
    With the use of a mouse model expressing human Fc-gamma receptors (FcγRs), we demonstrated that antibodies with isotypes equivalent to ipilimumab and tremelimumab mediate intra-tumoral regulatory T (Treg) cell depletion in vivo, increasing the CD8+ to Treg cell ratio and promoting tumor rejection. Antibodies with improved FcγR binding profiles drove superior anti-tumor responses and survival. In patients with advanced melanoma, response to ipilimumab was associated with the CD16a-V158F high affinity polymorphism. Such activity only appeared relevant in the context of inflamed tumors, explaining the modest response rates observed in the clinical setting. Our data suggest that the activity of anti-CTLA-4 in inflamed tumors may be improved through enhancement of FcγR binding, whereas poorly infiltrated tumors will likely require combination approaches
    • …
    corecore